A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.
Clinical trial NCT00261560 · COMPLETED
Trial details
- NCT number
- NCT00261560
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.